Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Anesthesiology
  4. Propofol promotes spinal cord injury repair by bone marrow mesenchymal stem cell transplantation

Propofol promotes spinal cord injury repair by bone marrow mesenchymal stem cell transplantation

Neural Regeneration Research, 2015 · DOI: 10.4103/1673-5374.162765 · Published: August 1, 2015

AnesthesiologyRegenerative MedicineNeurology

Simple Explanation

The study investigates whether propofol, a neuroprotective anesthetic, can enhance spinal cord injury repair when combined with bone marrow mesenchymal stem cell (BMSC) transplantation. Rats with spinal cord injuries were treated with either propofol, BMSC transplantation, a combination of both, or a control. The results showed that the combination therapy led to better spinal cord repair and improved motor function compared to individual treatments. The researchers suggest that propofol may increase the survival rate of BMSCs in the injured spinal cord, thus optimizing spinal cord injury repair.

Study Duration
4 weeks
Participants
80 healthy female adult Wistar rats
Evidence Level
Not specified

Key Findings

  • 1
    Combined propofol and BMSC transplantation significantly improved hindlimb motor function in rats with spinal cord injury compared to monotherapy.
  • 2
    The combination therapy resulted in smaller cavities in the injured spinal cord tissue and a greater number of CM-Dil-positive cells compared to monotherapy.
  • 3
    Propofol infusion combined with BMSC transplantation increased the number of fluorogold-labeled nerve fibers in the injured rat spinal cord on the cranial side.

Research Summary

This study aimed to validate neuroprotective effects of combined therapy (propofol and bone marrow mesenchymal stem cells (BMSCs)) on rat spinal cord injury. Results indicate that propofol can enhance the therapeutic effects of bone marrow mesenchymal stem cell transplantation on spinal cord injury in rats. Propofol infusion via the tail vein using an infusion pump can increase the survival rate of BMSCs in the injured spinal cord and optimize the repair of spinal cord injury in rats by BMSC transplantation.

Practical Implications

Enhanced Spinal Cord Repair

The study suggests that combining propofol with BMSC transplantation can enhance spinal cord injury repair more effectively than using either treatment alone.

Clinical Potential

The findings suggest that this combined therapy could be a promising approach for treating spinal cord injuries in clinical settings.

Neuroprotective Mechanisms

The study provides insights into the potential mechanisms by which propofol may protect and promote neuronal regeneration in the injured spinal cord.

Study Limitations

  • 1
    The study was conducted on rats, and the results may not be directly applicable to humans.
  • 2
    Further research is needed to fully understand the underlying mechanisms of the combined therapy.
  • 3
    The optimal dosage and timing of propofol administration in combination with BMSC transplantation need to be determined.

Your Feedback

Was this summary helpful?

Back to Anesthesiology